%0 Clinical Trial, Phase I
%T A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
%A Gordon MJ
%A Dubois S
%A Bryant B
%A Ng S
%A Conlon K
%A Miljkovic MD
%A Waldmann T
%A Roschewski M
%J Leuk Lymphoma
%V 65
%N 7
%D 2024 Jul 9
%M 38459780
暂无%R 10.1080/10428194.2024.2326847